Correlation Between Assembly Biosciences and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Assembly Biosciences and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assembly Biosciences and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Assembly Biosciences and Akari Therapeutics PLC, you can compare the effects of market volatilities on Assembly Biosciences and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assembly Biosciences with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assembly Biosciences and Akari Therapeutics.
Diversification Opportunities for Assembly Biosciences and Akari Therapeutics
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Assembly and Akari is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Assembly Biosciences and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Assembly Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assembly Biosciences are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Assembly Biosciences i.e., Assembly Biosciences and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Assembly Biosciences and Akari Therapeutics
Given the investment horizon of 90 days Assembly Biosciences is expected to generate 0.55 times more return on investment than Akari Therapeutics. However, Assembly Biosciences is 1.83 times less risky than Akari Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Akari Therapeutics PLC is currently generating about -0.02 per unit of risk. If you would invest 984.00 in Assembly Biosciences on August 25, 2024 and sell it today you would earn a total of 520.00 from holding Assembly Biosciences or generate 52.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 99.56% |
| Values | Daily Returns |
Assembly Biosciences vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Assembly Biosciences |
| Akari Therapeutics PLC |
Assembly Biosciences and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Assembly Biosciences and Akari Therapeutics
The main advantage of trading using opposite Assembly Biosciences and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assembly Biosciences position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Assembly Biosciences vs. Eliem Therapeutics | Assembly Biosciences vs. HCW Biologics | Assembly Biosciences vs. Scpharmaceuticals | Assembly Biosciences vs. Milestone Pharmaceuticals |
| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |